Preventing the Impact of Hyperglycemia and Diabetes on Patients Undergoing Total Joint Arthroplasty.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37271552.
- Also identified by DOI 10.1016/j.ocl.2023.02.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Primary and revision total joint arthroplasty (TJA) procedures have become increasingly popular worldwide. At the same time, a growing number of patients undergoing TJA are either known diabetics or exhibit evidence of hyperglycemia preoperatively. Based on extensive data, it is well-established that poor glycemic control in TJA patients is an independent risk factor for several complications, including periprosthetic joint infection and death. This article will serve as an overview of currently available evidence on how to prevent the impact of hyperglycemia and diabetes mellitus on patients undergoing TJA.
Medical subject headings
- Arthroplasty, Replacement, Knee
- Arthroplasty, Replacement, Hip
- Prosthesis-Related Infections
- Diabetes Mellitus
- Hyperglycemia
Anatomy
- knee
- hip